poisar

Stocks · News reference

Circio Collaborates with Solid Biosciences to Develop Genetic Heart Disease Gene Therapy

Fiscal.ai

Circio Holding ASA has entered into a collaboration with Solid Biosciences to advance the development of a gene therapy candidate for genetic heart disease.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading